Skip to main content
Erschienen in: Supportive Care in Cancer 4/2020

24.10.2019 | Letter to the Editor

Olanzapine: Sancho Panza for clinicians who care for patients with advanced cancer

verfasst von: Ali Alkan, Özgür Tanrıverdi

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

To the editor, …
Literatur
1.
Zurück zum Zitat Gupta M, Davis M, LeGrand S, Walsh D, Lagman R (2013) Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol. J Support Oncol 11(1):8–13PubMed Gupta M, Davis M, LeGrand S, Walsh D, Lagman R (2013) Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol. J Support Oncol 11(1):8–13PubMed
2.
Zurück zum Zitat Srivastava M, Brito-Dellan N, Davis MP, Leach M, Lagman R (2003) Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manag 25(6):578–582CrossRef Srivastava M, Brito-Dellan N, Davis MP, Leach M, Lagman R (2003) Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manag 25(6):578–582CrossRef
3.
Zurück zum Zitat Yang T, Liu Q, Lu M, Ma L, Zhou Y, Cui Y (2017) Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis. Br J Clin Pharmacol 83(7):1369–1379CrossRef Yang T, Liu Q, Lu M, Ma L, Zhou Y, Cui Y (2017) Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis. Br J Clin Pharmacol 83(7):1369–1379CrossRef
4.
Zurück zum Zitat Harder S, Groenvold M, Isaksen J, Sigaard J, Frandsen KB, Neergaard MA, Mondrup L, Herrstedt J (2019) Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study. Support Care Cancer 27(8):2849–2856CrossRef Harder S, Groenvold M, Isaksen J, Sigaard J, Frandsen KB, Neergaard MA, Mondrup L, Herrstedt J (2019) Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study. Support Care Cancer 27(8):2849–2856CrossRef
5.
Zurück zum Zitat Alkan A, Yasar A, Karci E, Koksoy EB, Urun M, Senler FC et al (2017) Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients. Support Care Cancer 25(1):229–236CrossRef Alkan A, Yasar A, Karci E, Koksoy EB, Urun M, Senler FC et al (2017) Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients. Support Care Cancer 25(1):229–236CrossRef
Metadaten
Titel
Olanzapine: Sancho Panza for clinicians who care for patients with advanced cancer
verfasst von
Ali Alkan
Özgür Tanrıverdi
Publikationsdatum
24.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05105-4

Weitere Artikel der Ausgabe 4/2020

Supportive Care in Cancer 4/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.